1. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma
   A Galal El-Shemi et al, 2018, Gene Ther CrossRef
2. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma
   Pei Ye et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. Ultrasound-guided intertumoral injection of contrast agents combined with human p53 gene for the treatment of breast cancer
   Jun-Cheng Guo et al, 2018, The Kaohsiung Journal of Medical Sciences CrossRef
4. The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders
   Yang Du et al, 2019, Biosci. Rep. CrossRef
5. Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy
   Aymen Shatnawi et al, 2019, Mol Cell Biochem CrossRef
6. Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer.
   Aymen Shatnawi et al, 2021, Adv Cancer Res CrossRef
7. Enhanced effect of recombinant adenoviruses co‐expression of ING4 and OSM on anti‐tumour activity of laryngeal cancer
   Fuwei Cheng et al, 2022, J Cellular Molecular Medi CrossRef
8. p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons
   Camil Ciprian Mireștean et al, 2022, Diagnostics CrossRef
9. Targeting Antheraea pernyi silk fibroin modified dual-gene coexpressing vector enhances gene transport and promotes lung tumor suppression
   Jing Qu et al, 2024, International Journal of Biological Macromolecules CrossRef